|
|
|
The REST (RLS Epidemiology, Symptoms and Treatment) Study in Primary Care, funded by GlaxoSmithKline, included all patients (n = 23,052) visiting 182 primary care doctors in the United States and Western Europe over a 2-week period. Of the 551 patients self-reported as "RLS sufferers" by the validated study criteria, selected survey findings included4,8:
- 68.6% reported taking more than 30 minutes to get to sleep
- 60.1% reported waking 3 or more times per night
- 60.8% reported that they lacked energy when experiencing RLS symptoms
- 60.1% found it difficult to sit or relax
- 57.2% stated that their daily activities were disturbed
|